Dr. Puja Nistala
Claim this profileUniversity of Missouri - Ellis Fischel
Studies Parotid Gland Cancer
Studies Breast Cancer
26 reported clinical trials
86 drugs studied
About Puja Nistala
Education:
- Earned an MD (Doctor of Medicine).
- Holds an MBBS (Bachelor of Medicine, Bachelor of Surgery).
Experience:
- Serves as the Margaret Proctor Mulligan Assistant Professor of Clinical Medicine at the University of Missouri.
- Acts as the Medical Director of the Clinical Trials Office at Ellis Fischel Cancer Center.
- Oncology Breast Program Director at Ellis Fischel Cancer Center.
Area of expertise
1Parotid Gland Cancer
Stage IV
HER2 positive
Stage II
2Breast Cancer
HER2 positive
ER positive
Stage IV
Affiliated Hospitals
Clinical Trials Puja Nistala is currently running
Eribulin + Chemotherapy
for Bladder Cancer
This phase III trial compares the usual chemotherapy treatment to eribulin plus gemcitabine in treating patients with urothelial cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as eribulin, gemcitabine, docetaxel, paclitaxel, and sacituzumab govitecan work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial aims to see whether adding eribulin to standard of care chemotherapy may work better in treating patients with metastatic urothelial cancer.
Recruiting2 awards Phase 3
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Puja Nistala
Clinical Trial Related3 years of experience running clinical trials · Led 26 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Puja Nistala has experience with
- Radiation Therapy
- Paclitaxel
- Atezolizumab
- Biospecimen Collection
- Gemcitabine Hydrochloride
- Oxaliplatin
Breakdown of trials Puja Nistala has run
Parotid Gland Cancer
Breast Cancer
Breast cancer
Lung Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
What does Puja Nistala specialize in?
Is Puja Nistala currently recruiting for clinical trials?
Are there any treatments that Puja Nistala has studied deeply?
What is the best way to schedule an appointment with Puja Nistala?
What is the office address of Puja Nistala?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.